Hematogenix

Hematogenix is a global leader in cancer-focused life science solutions, dedicated to serving the pharmaceutical and biotechnology industries, as well as community physicians. Hematogenix is committed to advancing cancer research and patient care through cutting-edge biomarker development and testing services. Hematogenix's passionate team of scientists and board-certified clinical and anatomic pathologists and hematopathologists work to navigate the complexities of human diseases and clinical trials.

Hematogenix provides a comprehensive menu of services including Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology, and Image Analysis. Hematogenix is uniquely equipped to accelerate cancer research and drug development efforts with globally connected facilities. The primary address is 8150 W. 185th Street, Ste. A, Tinley Park, IL 60487, US, with an additional location at BioHub, Mereside, Alderley Park, Macclesfield SK10 4TG, GB.

Hematogenix is committed to utilizing the most advanced techniques to enhance patient care. They provide customized services ranging from the initial stages of research to development, extending all the way to the implementation of targeted therapies in the clinical setting. We invite the management team at Hematogenix to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional capabilities.